News About Covid 19
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as “a game changer” that should speed a return to normal economic life.
Russian hospitals can begin giving the drug to patients from June 11, with enough to treat around 60,000 people per month, the head of Russia’s RDIF sovereign wealth fund told Reuters in an interview.
There is currently no approved vaccine for the highly contagious and sometimes fatal illness and no consensus within the global scientific community about the efficacy of medication such as the Russian modified antiviral drug.
Registered under the name Avifavir, it is the first potential coronavirus treatment to be approved by Russia’s health ministry, however. It appeared on a government list of approved drugs on May 30 after clinical trials.
RDIF head Kirill Dmitriev said clinical trials involved 330 people and showed that the drug successfully treated the virus in most cases within four days.
Trials were due to be concluded in around a week, he said, and more would be conducted. The health ministry had given its approval for the drug’s use under a special accelerated process and manufacturing had begun in March, he added.
See Our Other Links:
http://www.studyup.com/notes/view/41020
https://www.deviantart.com/lawfirminlahore
https://www.bloglovin.com/@bestlawfirminlahorepakistanforsuccessinyoursuit
https://disqus.com/by/disqus_mAxBFbsIZh/
https://medium.com/@favigi2373
https://www.vingle.net/LawFirminLahore
https://www.sbnation.com/users/TopLawFirminLahorePakistanForSuccessInYourCase
Sign up and follow your favorite conferences.